These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25376296)

  • 21. Clinical implications of cancer stem cell biology in hepatocellular carcinoma.
    Ji J; Wang XW
    Semin Oncol; 2012 Aug; 39(4):461-72. PubMed ID: 22846863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of diagnostic utility and expression profiles of stem cell markers (CD133 and CD90) in hepatocellular carcinoma, small cell dysplasia, and cirrhosis.
    Yilmaz G; Akyol G; Cakir A; Ilhan M
    Pathol Res Pract; 2014 Jul; 210(7):419-25. PubMed ID: 24702884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Keratin 19 protein expression is an independent predictor of survival in human hepatocellular carcinoma.
    Fatourou E; Koskinas J; Karandrea D; Palaiologou M; Syminelaki T; Karanikolas M; Felekouras E; Antoniou E; Manesis EK; Delladetsima J; Tiniakos D
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1094-102. PubMed ID: 26011233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic alterations and expression of PTEN and its relationship with cancer stem cell markers to investigate pathogenesis and to evaluate prognosis in hepatocellular carcinoma.
    Chen D; Li Z; Cheng Q; Wang Y; Qian L; Gao J; Zhu JY
    J Clin Pathol; 2019 Sep; 72(9):588-596. PubMed ID: 31126975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    Terris B; Cavard C; Perret C
    J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma.
    Song W; Li H; Tao K; Li R; Song Z; Zhao Q; Zhang F; Dou K
    Int J Clin Pract; 2008 Aug; 62(8):1212-8. PubMed ID: 18479363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface markers of hepatocellular cancer stem cells and their clinical potential.
    Feng D; Wang N; Hu J; Li W
    Neoplasma; 2014; 61(5):505-13. PubMed ID: 24712843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stemness characteristics of fibrolamellar hepatocellular carcinoma: immunohistochemical analysis with comparisons to conventional hepatocellular carcinoma.
    Zenali MJ; Tan D; Li W; Dhingra S; Brown RE
    Ann Clin Lab Sci; 2010; 40(2):126-34. PubMed ID: 20421623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
    Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
    Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.
    Rhee H; Kim H; Park YN
    Liver Cancer; 2020 Dec; 9(6):663-681. PubMed ID: 33442539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinoma.
    Lai JP; Conley A; Knudsen BS; Guindi M
    Histopathology; 2015 Oct; 67(4):442-50. PubMed ID: 25425262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients.
    Takami H; Kanda M; Oya H; Hibino S; Sugimoto H; Suenaga M; Yamada S; Nishikawa Y; Asai M; Fujii T; Nomoto S; Kodera Y
    J Surg Oncol; 2013 Dec; 108(8):557-62. PubMed ID: 24068544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI features of hepatocellular carcinoma expressing progenitor cell markers.
    Jeong HT; Kim MJ; Kim YE; Park YN; Choi GH; Choi JS
    Liver Int; 2012 Mar; 32(3):430-40. PubMed ID: 22097930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
    Yamashita T; Forgues M; Wang W; Kim JW; Ye Q; Jia H; Budhu A; Zanetti KA; Chen Y; Qin LX; Tang ZY; Wang XW
    Cancer Res; 2008 Mar; 68(5):1451-61. PubMed ID: 18316609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological indices to predict hepatocellular carcinoma molecular classification.
    Tan PS; Nakagawa S; Goossens N; Venkatesh A; Huang T; Ward SC; Sun X; Song WM; Koh A; Canasto-Chibuque C; Deshmukh M; Nair V; Mahajan M; Zhang B; Fiel MI; Kobayashi M; Kumada H; Hoshida Y
    Liver Int; 2016 Jan; 36(1):108-18. PubMed ID: 26058462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Childhood hepatocellular carcinoma: a clinicopathological study of 12 cases with special reference to EpCAM.
    Zen Y; Vara R; Portmann B; Hadzic N
    Histopathology; 2014 Apr; 64(5):671-82. PubMed ID: 24138022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of stemness markers and altered tumor stroma in hepatocellular carcinoma under TACE-induced hypoxia: A biopsy and resection matched study.
    Nahm JH; Rhee H; Kim H; Yoo JE; San Lee J; Jeon Y; Choi GH; Park YN
    Oncotarget; 2017 Nov; 8(59):99359-99371. PubMed ID: 29245907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SALL4 Expression in Hepatocellular Carcinomas Is Associated with EpCAM-Positivity and a Poor Prognosis.
    Park H; Lee H; Seo AN; Cho JY; Choi YR; Yoon YS; Han HS; Park YN; Kim H
    J Pathol Transl Med; 2015 Sep; 49(5):373-81. PubMed ID: 26265684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Epithelial Cell Adhesion Molecule Cancer Stem Cell Marker in Evaluation of Hepatocellular Carcinoma.
    El-Kholy MA; Abu-Seadah SS; Hasan A; Elhussiny MEA; Abdelwahed MS; Hanbazazh M; Samman A; Alrashdi SA; Rashed ZF; Ashmawy D; Othman AE; Abdelaleem MF; Abo-Saif AIA; Abdel-Maqsoud RR; Attiah SM; Assiri ES; Nasr M; Ismail KA; Saad DZ; El-Mosely MM
    Medicina (Kaunas); 2024 May; 60(6):. PubMed ID: 38929532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.